during ablation of symptomatic monomorphic PVCs originating from the RVOT; 2) normal ejection fraction (EF) ≥60%; 3) no history of sustained ventricular tachycardia (VT) or VF; 4) no history of myocardial infarction, diagnosed cardiomyopathy, or any abnormalities on electrocardiography (ECG) suggesting additional electrical disease. Six patients (5 men) fulfilled the above criteria. The mean (SD) age of patients was 35.2 (16.8) years. In all patients, ventricular arrhythmia required cessation of the RF delivery, and in 5 patients, a transthoracic external cardioversion delivery was required (FIGURE 1). One patient had nonsustained self -terminating VF (FIGURE 2). VF episodes occurred during normal state and were not connected with isoproterenol infusion.
The study was conducted according to the principles of the Declaration of Helsinki. All patients provided written informed consent for the ablation procedure and for the scientific data analysis. The consent for the procedure was approved by the institutional ethics committee.
Electrophysiological study and catheter ablation
An electrophysiological study was performed in the fasting and sedated state. All patients signed group of patients (class I recommendation).
1,2
Application of radiofrequency (RF) energy in sinus rhythm at the earliest activation of the PVC site induces repetitive PVCs or tachycardia with QRS morphology similar to the PVCs as a result of an increase in the temperature of calcium--overloaded cells and the development of afterdepolarization, and subsequent triggered activity.
3 In some patients, the rapid acceleration of ventricular arrhythmia induced by RF application may lead to ventricular fibrillation (VF).
4
Implantation of implantable cardioverter--defibrillator (ICD) and frequent discharges can lead to posttraumatic stress disorder.
5
The aim of the study was to define long-term risk of sudden cardiac death in patients with inadvertenly induced VF by RF application during ablation of PVCs originating from the RVOT.
PATIENTS AND METHODS Study population
We retrospectively analyzed the data of over 20 000 patients (2008-2016) who had been referred to 5 tertiary centers specialized in RF catheter ablation for all types of arrhythmias. We included patients based on the following criteria: 1) VF inadvertently induced by RF application recurrence during 24 hours of postprocedural hospital ECG monitoring. In all patients, antiarrhythmic drugs were not reinitiated if ablation was acutely successful.
Follow -up
The follow -up data were obtained from hospital and outpatient clinic records. The evaluation of the patients comprised clinical history, physical examination, a 12 -lead ECG, echocardiography, 24-hour Holter monitoring, exercise test, magnetic resonance imaging (MRI), electrophysiological study, and coronary angiography in patients with risk factors for ischemic heart disease. All patients were evaluated at least 3 times. Holter monitoring was performed at an interval of 6 months in the first year after the last successful RF ablation procedure and at an interval of 12 months thereafter. Patients were asked systematically about symptoms of recurrent arrhythmias and encouraged to notify the clinic in the case of recurrence at any time during the follow -up. Patients with recurrent arrhythmia were offered a repeat ablation. In 4 of 6 patients, MRI was performed. One patient received an ICD and we checked the device regularly.
Statistical analysis Categorical variables were expressed as numbers and percentages, and continuous variables-as median and range or mean with 1 standard deviation. Categorical variables were compared using the χ 2 test. A P value of less than 0.05 was considered significant. Analyses were performed using SPSS software (IBM, Armonk, New York, United States).
RESULTS
The baseline characteristics of the patients are presented in We used ThermoCool catheter in 4 patients, Smart Touch catheter in 1 patient, and Celsius DS ablation catheter in 1 patient (all catheters, Biosense Webster).
VFs occurred during normal state and were not associated with infusion of isoproterenol or other β -mimetics.
All patients had frequent PVCs with a preablation burden of 23% to 42% and with no evidence of decreased left ventricular function. The mean (SD) left ventricular EF was 65.5% (4.8%). One patient had stable coronary artery disease (coronary angioplasty and stent implantation in the right coronary artery 3 years prior to RF ablation, without any complaints and normal exercise test results). After VF episodes, contrast--enhanced MRI was performed in 4 patients but did not show any area of late gadolinium enhancement. An electrophysiological study and ventricular stimulation performed in 1 patient 6 months after the VF episode did not show ventricular arrhythmia. An exercise test performed in all patients after ablation did not reveal any an informed consent prior to the ablation procedure. Antiarrhythmic drugs were discontinued at least 5 half -lives before the procedure. A heparin bolus of 50 to 100 IU/kg was administered, and after each hour, another bolus of 1000 IU was administered. Intracardiac bipolar electrograms, as well as 12 -lead ECG, were recorded digitally. All measurements were performed using on -screen electronic calipers at a sweep speed of 100 to 200 mm/s and gain setting of 0.1 to 0.2 mV/cm. The following catheters, in accordance with the study protocol, were used: 1) a 7 F steerable, diagnostic quadripolar catheter with 2-5-2 mm interelectrode spacing (Marinr MCXL, Medtronic, Inc., Minneapolis, Minnesota, United States) placed in the coronary sinus; and 2) ablation catheters: an 8 F irrigated -tip catheter or DS ablation catheter (Biosense Webster, Inc., Diamond Bar, California, United States).
The origin of PVCs was determined based on detailed activation and pace mapping. In particular, during activation mapping, the local activation time was consistently measured from the onset of the electrogram (earliest positive or negative deflection) of the mapping catheter's distal bipole to the earliest onset of the QRS complex in any of the 12 ECG leads and to the steepest negative deflection in the unipolar signal displayed in the mapping system. Activation times were measured by 2 independent observers and displayed on a 3 -dimensional electroanatomic map. We used a 3 -dimensional system CARTO XP or CARTO 3 system (Biosense Webster, Inc.) or EnSite™ NavX (St. Jude Medical, St. Paul, Minnesota, United States). Stimulator pins were not connected to the direct ports on the Carto 3 system. RF energy was delivered with a power of 35 W and a maximum temperature of 45°C. Acute success was defined as elimination of clinical arrhythmia during RF and the inability to induce clinical PVCs at the end of the procedure, with no Study limitations This was a retrospective analysis; therefore, several limitations must be considered. The main limitation was the small number of enrolled patients. Moreover, not all data concerning the ablation procedures were available. VF during RF ablation could result from current leak in the ablation system. This may be caused by shortening and inadequate grounding of the current leak. Nevertheless, in our study, VF occurred independently in 5 electrophysiological labs, and the above mechanism seems to be extremely rare.
Conclusions
Patients with VF inadvertently induced by RF energy application during the ablation of monomorphic PVCs originating from the RVOT, who have normal left ventricular function on echocardiography and no ECG abnormalities suggesting additional electrical disease, have a good prognosis and a low risk of VF during long--term follow -up. Therefore, ICD placement seems not to be indicated in these patients.
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